Related Experiment Video
Updated: Oct 10, 2025
09:30
Bacterial Detection & Identification Using Electrochemical Sensors
Published on: April 23, 2013
28.5K
A novel real-time TMAO detection method based on microbial electrochemical technology.
Yue Yi1, Axin Liang1, Lin Luo1
1School of Life Science, Beijing Institute of Technology, Beijing 100081, China; Key Laboratory of Molecular Medicine and Biotherapy, Ministry of Industry and Information Technology, Beijing Institute of Technology, Beijing 100081, China.
Bioelectrochemistry (Amsterdam, Netherlands)
|December 15, 2021
Summary
A new microbial electrochemical method offers real-time detection of trimethylamine N-oxide (TMAO), a cardiovascular disease biomarker. This innovation converts TMAO levels into electrical signals for faster, point-of-care diagnostics.
Area of Science:
- Biomedical Engineering
- Microbiology
- Analytical Chemistry
Background:
- Trimethylamine N-oxide (TMAO) is an emerging biomarker for cardiovascular diseases.
- Current TMAO detection methods lack the speed and portability for real-time and point-of-care applications.
Purpose of the Study:
- To develop a novel microbial electrochemical sensor for direct and rapid detection of TMAO.
- To assess the performance of the sensor in terms of sensitivity, linearity, and accuracy for clinical use.
Main Methods:
- Utilized Shewanella loihica PV-4, a bacterium capable of extracellular electron transfer and TMAO reduction.
- Established a microbial electrochemical system to convert TMAO concentration into measurable electrical signals.
- Validated the sensor's performance using standard solutions and real human serum samples.
Main Results:
- The sensor demonstrated a wide linear detection range from 0 to 250 μM.
- Achieved high sensitivity (23.92 μA/mM) and a low limit of detection (5.96 μM).
- Completed detection within 600 seconds with 90% accuracy in real serum, indicating clinical feasibility.
Conclusions:
- The developed microbial electrochemical method provides a sensitive, rapid, and accurate approach for TMAO detection.
- This technology holds significant potential for point-of-care cardiovascular disease diagnostics.
- Shewanella loihica PV-4 is a viable microbial agent for electrochemical biosensing applications.
